Antioxidant effect of endothelin-1 receptor antagonist protects the rat kidney against chronic injury induced by hypertension and hyperglycemia
ABSTRACT Hypertension and Diabetes mellitus are the two main causes of chronic kidney disease that culminate in the final stage of kidney disease. Since these two risk factors are common and can overlap, new approaches to prevent or treat them are needed. Macitentan (MAC) is a new non-selective anta...
Main Authors: | Agnaldo Caires, Marcia Bastos Convento, Bianca Castino, Ala Moana Leme, Edson de Andrade Pessoa, Alef Aragão, Nestor Schor, Fernanda Teixeira Borges |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Nefrologia
|
Series: | Brazilian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002019005027101&lng=en&tlng=en |
Similar Items
-
Pharmacological Potential of Endothelin Receptors Agonists and Antagonists
by: Jiří Patočka, et al.
Published: (2005-01-01) -
Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats
by: A. Caires, et al.
Published: (2017-12-01) -
Endothelin receptor antagonists
– a brief description of the new class of drugs
by: Agata Kowalczyk, et al.
Published: (2014-01-01) -
Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension
by: N A Tsareva
Published: (2013-12-01) -
ANTIDIURETIC EFFECTS OF THE ENDOTHELIN RECEPTOR ANTAGONIST AVOSENTAN
by: Ovidiu Constantin Baltatu, et al.
Published: (2012-04-01)